ReviewCurrent pain and headache reports2009
Migraine headache in perimenopausal and menopausal women.
Review in Current pain and headache reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 48 citations in OpenAlex.
- A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.Reproductive biology and endocrinology : RB&E · 2020Trial
- Statin-Associated Headache: A Rare and Underrecognized Clinical Presentation: A Case Report.Reports (MDPI) · 2025Article
- Study to Determine the Prevalence of Menstrual Migraine in Reproductive-Age Women in Saudi Arabia.Healthcare (Basel, Switzerland) · 2024Article
- The Inverse Correlation of Isoflavone Dietary Intake and Headache in Peri- and Post-Menopausal Women.Nutrients · 2022Article
- Article
- The impact of midlife on migraine in women: summary of current views.Women's midlife health · 2020Review
- Review
- Prevalence and Clinical Factors of Migraine in Patients With Spontaneous Coronary Artery Dissection.Journal of the American Heart Association · 2018Article
- Evaluation and management of migraine in midlife women.Menopause (New York, N.Y.) · 2018Article
- Estrogen, migraine, and vascular risk.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018Review
- Women and Migraine: the Role of Hormones.Current neurology and neuroscience reports · 2018Review
- Characteristics of Elderly-Onset (≥65 years) Headache Diagnosed Using the International Classification of Headache Disorders, Third Edition Beta Version.Journal of clinical neurology (Seoul, Korea) · 2016Article
- Migraine in perimenopausal women.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2015Review
- Migraine in menopausal women: a systematic review.International journal of women's health · 2015Review
- Effects of the kampo formula tokishakuyakusan on headaches and concomitant depression in middle-aged women.Evidence-based complementary and alternative medicine : eCAM · 2014Article
- Studies on the pathophysiology and genetic basis of migraine.Current genomics · 2013Article
- Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer.Hormones & cancer · 2012Article
- Migraine changes the brain: neuroimaging makes its mark.Current opinion in neurology · 2012Review
- Sex differences in the inflammatory mediator-induced sensitization of dural afferents.Journal of neurophysiology · 2011Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perimenopause marks a time of change in a woman's hormonal environment, which is apparent from the resultant irregular periods and vasomotor symptoms. These symptoms can start in the early 40s and continue through to the early 50s. Migraine is also affected by hormonal fluctuations, particularly the natural decline in estrogen in the late luteal phase of the menstrual cycle. This effect of estrogen "withdrawal" on migraine appears to become more predominant during perimenopause. Despite the increased prevalence of headache and migraine in women in their 40s, migraine is underdiagnosed in this population. In women attending with symptoms suggestive of perimenopause, it is important to ask about headache symptoms. Once diagnosed, a number of strategies can be used to manage both perimenopausal migraine and menopausal symptoms effectively, with the potential to reduce the associated morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.